17-beta-oestradiol and the fibrinolytic activity on vein walls.
D000510:Alpha-Globulins / Q000032:analysis; D000933:Antifibrinolytic Agents; D000991:Antithrombins / Q000032:analysis; D001706:Biopsy; D001777:Blood Coagulation / Q000187:drug effects; D002979:Climacteric; D004958:Estradiol / Q000494:pharmacology*; D005165:Factor V / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D005169:Factor VIII / Q000032:analysis; D005170:Factor X / Q000032:analysis; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008593:Menopause; D010958:Plasminogen / Q000032:analysis; D011516:Prothrombin / Q000032:analysis; D014680:Veins / Q000378:metabolism* / Q000473:pathology; D014690:Venous Pressure
D000510:Alpha-Globulins; D000933:Antifibrinolytic Agents; D000991:Antithrombins; D004958:Estradiol; D005165:Factor V; D005167:Factor VII; D011516:Prothrombin; D005169:Factor VIII; D005170:Factor X; D005340:Fibrinogen; D010958:Plasminogen